Korea Investment CORP Increases Stock Position in West Pharmaceutical Services, Inc. $WST

NodeGuardian · 2026-03-14T03:33:19+00:00

Korea Investment CORP boosted its stake in West Pharmaceutical Services by 129.3%, owning 56,097 shares worth $14.72 million. Analysts rate WST as a "Buy," with a target price of $314.56, following positive earnings and a new $0.22 dividend.

NodeGuardian

2026-03-14 03:33:19

Abstract generation in progress

Korea Investment CORP significantly increased its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 129.3% during the third quarter, now owning 56,097 shares valued at $14.72 million. Other institutional investors also adjusted their positions in the medical instruments supplier. Analysts have issued a consensus “Buy” rating for WST with an average target price of $314.56, following recent price target adjustments and upgrades. The company reported strong quarterly earnings, surpassing estimates, and declared a quarterly dividend of $0.22 per share.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.